Summary pursuant to sections 52 to 55 of the Constitution.
Keywords foreign and European Affairs, INTERNATIONAL, MULTILATERAL agreement, UNESCO, international CONVENTION agreement, SPORTS, sport, SUBSTANCE DOPANTE, STIMULANT, ban, fight against the DOPING, COMPETITION sport DOPING control authority competent JORF n ° 0293 December 18, 2010 page 22297 text no. 7 order No. 2010-1578 of December 16, 2010, on the publication of the amendment to the annex of the convention against doping, adopted on 8 and 9 November 2009 in Strasbourg , and annex 1 of the international convention against doping in sport, adopted in Paris on 17 November 2010 (1) NOR: MAEJ1031122D ELI: https://www.legifrance.gouv.fr/eli/decret/2010/12/16/MAEJ1031122D/jo/texte Alias: https://www.legifrance.gouv.fr/eli/decret/2010/12/16/2010-1578/jo/texte the President of the Republic, on the report of the Prime Minister and the Minister of State Minister of foreign and European Affairs, pursuant to the Constitution, including its articles 52 to 55;
Having regard to Decree No. 53-192, 14 March 1953 as amended relating to the ratification and the publication of the international commitments entered into by France;
Considering Decree No. 2007-503 of 2 April 2007 on the publication of the international convention against doping in sport (two annexes), adopted in Paris on 19 October 2005;
Considering Decree No. 2008-35, January 10, 2008, on the publication of the amendment to the annex of the convention against doping, adopted on 12 November 2007 in Madrid;
Considering Decree No. 2009-93 of January 26, 2009 on the publication of the amendment to the annex of the convention against doping, adopted on November 13, 2008 in Strasbourg, and in annex 1 of the international convention against doping in sport, adopted on 17 November 2008 in Paris.
Mindful of Decree No. 2010-134 of 10 February 2010 on the publication of the amendment to the appendix to the anti-doping convention, adopted on November 18, 2009 in Strasbourg and in annex 1 of the international convention against doping in sport, adopted in Paris on October 28, 2009, enacts as follows: Article 1 the amendment to the annex to the convention against doping adopted on 8 and 9 November 2009 in Strasbourg and in annex 1 of the international convention against doping in sport, adopted in Paris on 17 November 2010, will be published in the Official Journal of the French Republic.


Article 2 the Prime Minister and the Minister of State, Minister of foreign and European Affairs, are responsible, each in relation to the implementation of this Decree, which shall be published in the Official Journal of the French Republic.

Annex L I S T E of SUBSTANCES and methods prohibited in SPORT (list 2011) World Anti-Doping Code 2011 INTERNATIONAL STANDARD prohibited list this list shall enter into force on January 1, 2011.
THE 2011 world anti-DOPING CODE prohibited list entered into force on January 1, 2011 all prohibited substances shall be considered as "specified substances" except substances in classes S1, S2.1 S2.5, S4.4 and S6.a, and prohibited methods M1, M2 and M3.
SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN AND OUT OF COMPETITION) S0. SUBSTANCES not approved any pharmacological substance not included in a section from the list below and which is not currently approved for human administration by a government authority regulatory health (e.g. drugs in preclinical or clinical or discontinued development) is prohibited at all times.
S1 PROHIBITED SUBSTANCES. ANABOLIC AGENTS anabolic agents are prohibited.
1 Anabolic Androgenic Steroids (AAS) a. SAA exogenous *, including: 1-androstendiol (5-androst-1-ene-3,17-diol); 1 - androstenedione (5-androst-1-ene-3,17-dione); bolandiol (19-norandrostenediol); bolasterone; boldenone; boldione (androsta-1, 4-diene-3, 17-dione); calusterone; clostebol; danazol (17-ethynyl-17-hydroxyandrost-4-eno[2,3-d]isoxazole); dehydrochlormethyltestosterone (4-chloro-17-hydroxy-17-methylandrosta-1,4-diene-3-one); desoxymethyltestosterone (17-methyl-5-androst-2-en-17-ol); drostanolone; ethylestrenol (19-nor-17-pregn-4-en-17-ol); fluoxymesterone; formebolone; furazabol (17-hydroxy-17-methyl-5-androstano[2,3-c]-furazan); gestrinone; 4 - hydroxytestosterone (4,17-dihydroxyandrost-4-en-3-one); mestanolone; mesterolone; metenolone; methandienone (17-hydroxy-17-methylandrosta-1,4-diene-3-one); methandriol; methasterone (2, 17-dimethyl-5-androstane-3-one-17-ol); methyldienolone (17-hydroxy-17-methylestra-4,9-diene-3-one); methyl-1-testosterone (17-hydroxy-17-methyl-5-androst-1-en-3-one); (17-hydroxy-17-methylestr-4-en-3-one) methylnortestosterone; methyltestosterone; metribolone (methyltrienolone, 17-hydroxy-17-methylestra-4,9,11-triene-3-one); mibolerone; nandrolone; 19 - norandrostenedione (estr-4-ene-3, 17-dione); norboletone; norclostebol; norethandrolone; oxabolone; oxandrolone; oxymesterone; oxymetholone; prostanozol (17-hydroxy-5-androstano [3, 2 - c] pyrazole). quinbolone; stanozolol; stenbolone; 1-testosterone (17-hydroxy-5-androst-1-ene-3-one); Tetrahydrogestrinone (18a-homo-pregna-4,9,11-triene-17-ol-3-one); trenbolone; and other substances with a similar chemical structure or (a) effect (s) biological (s) similar (s).
b. SAA endogenous * by exogenously: androstenediol (androst-5-ene-3, 17-diol); androstenedione (androst-4-ene-3, 17-dione); dihydrotestosterone (17-hydroxy-5-androstan-3-one); prasterone (dehydroepiandrosterone, DHEA); testosterone and the following isomers and metabolites: 5-androstane-3, 17-diol; 5-androstane-3, 17-diol; 5-androstane-3, 17-diol; 5-androstane-3, 17-diol;
androst-4-ene-3, 17-diol; androst-4-ene-3, 17-diol; androst-4-ene-3, 17-diol; androst-5-ene-3, 17-diol; androst-5-ene-3, 17-diol; androst-5-ene-3, 17-diol; 4 - androstenediol (androst-4-ene-3, 17-diol); 5 - androstenedione (androst-5-ene-3, 17-dione); EPI-dihydrotestosterone; epitestosterone; 3-Hydroxy-5-androstan-17-one; 3-Hydroxy-5-androstan-17-one; 19 - norandrosterone; 19 - noretiocholanolone.
2. other anabolic agents, including but not limited to: Clenbuterol, selective receptor modulators (SARMs), tibolone, zeranol, zilpaterol androgen.
For the purposes of this document: * "exogenous" refers to a substance which cannot be usually produced naturally by the human body.
* "endogenous" refers to a substance which can be produced naturally by the human body.
S2. HORMONE peptide, factors of growth and SUBSTANCES related the following substances and their releasing factors are prohibited: 1. stimulating Agents of erythropoiesis [e.g. erythropoietin (EPO), darbepoetin (dEPO), methoxy polyethylene glycol-Epoetin beta (CERA), peginesatide (Hematide), stabilizers (HIF) hypoxia inducible factors];
2. chorionic gonadotrophin (CG) and luteinizing hormone (LH), banned in the sports of male only;
3 insulins;
4 Corticotrophs;
5 growth hormone (GH), insulin-1 (IGF-1)-like growth factor, growth factor derived from platelets (PDGF), endothelial growth factor vascular (VEGF), (HGF) hepatocyte growth factor, fibroblast growth factors (fgfs), mechanical growth factor (MGF), as well as any other growth factor influencing, in muscle, tendon or ligament, the protein synthesis/degradation vascularization, the use of energy, regenerative capacity or change of the type of fibre;
and other substances with a similar chemical structure or (a) effect (s) biological (s) similar (s).
S3. Beta-2 AGONISTS all beta-2 agonists (including their two optical isomers if applicable) are prohibited, except salbutamol (maximum 1 600 micrograms per 24 hours) and salmeterol inhalation according to the regimen recommended by the manufacturer.
The presence in the urine of salbutamol in a concentration greater than 1000 ng/mL will be deemed not to be a therapeutic intentional and will be considered as an adverse analytical finding unless the athlete proves by a controlled pharmacokinetic study that the abnormal result is the consequence of the use of a therapeutic dose (maximum of 1 600 micrograms per 24 hours) of salbutamol inhaled through.
S4. ANTAGONISTS and MODULATORS HORMONAUX the following classes of substances are prohibited: 1. aromatase inhibitors including but not limited to: aminoglutethimide, anastrozole, androsta-1, 4, 6-triene-3, 17-dione (androstatrienedione), 6, 17, 4-androstene-3 (6-oxo) trione, exemestane, formestane, letrozole, testolactone.
2 selective modulators (SERM) estrogen, including but not limited to: raloxifene, tamoxifen, toremifene.
3. other anti-estrogenic substances including but not limited to: clomiphene, cyclofenil, fulvestrant.
4-modifying agents (s) myostatin function (s), including but not limited to: myostatin inhibitors.
S5. DIURETICS and other MASKING AGENTS masking agents are prohibited. They include: diuretics, desmopressin, probenecid, plasma (e.g. glycerol; intravenous administration of albumin, dextran, hydroxyethyl starch and mannitol), and other substances possessing a (des) effect (s) biological (s) similar (s).
Diuretics include:

Acetazolamide, amiloride, bumetanide, canrenone, chlortalidone, ethacrynic acid, furosemide, indapamide, metolazone, spironolactone, thiazides (e.g. bendroflumethiazide, chlorothiazide, hydrochlorothiazide), triamterene, and other substances with a similar chemical structure or a (des) effect (s) biological (s) similar (s) (except for drosperinone, the pamabrome and the administration topical dorzolamide and brinzolamide, which are not banned).
The use in competition and out of competition if applicable, of any quantity of a substance is subject to a threshold level (e.g. salbutamol, morphine, cathine, ephedrine, methylephedrine, pseudoephedrine) together with a diuretic or another agent masking requires the issuance of a specific authorization of therapeutic use exemption for this substance, in addition to that obtained for the diuretic or another agent hiding.
M1 PROHIBITED METHODS. ENHANCEMENT of oxygen transfer the following is prohibited: 1. blood doping, including the use of autologous, homologous or heterologous blood or of red blood cells from all sources.
2 improving artificial consumption, transport or delivery of oxygen including, without limitation, chemicals perfluorochemicals, efaproxiral (RSR13) and the modified haemoglobin products (e.g. haemoglobin-based blood substitutes, cross-linked hemoglobin-based products), but excluding oxygen supplementation.
M2. HANDLING chemical and physics the following is prohibited: 1. tampering, or attempted tampering, in order to alter the integrity and validity of samples collected during doping control, is prohibited. This category includes, without limitation, catheterisation, the substitution and/or alteration of urine (e.g. proteases).
2. intravenous infusions are prohibited, except for those received legitimately in hospital admissions or clinical examinations.
3. the fact of successively to collect, manipulate and re - BREW whole blood in the circulatory system is prohibited.
M3. DOPING Genetics the following, with the potential ability to enhance athletic performance, is prohibited: 1. the transfer of nucleic acids or nucleic acid sequences;
2. the use of normal or genetically modified cells;
3. the use of agents affecting directly or indirectly known functions to influence sports performance by alteration of gene expression. For example, peroxisomes (PPAR) (e.g. GW 1516) proliferator-activated receptor agonists and agonists axis PPAR-activated protein kinase by AMP (AMPK) (e.g. AICAR) are prohibited.
SUBSTANCES and methods prohibited in COMPETITION in addition to the categories S0 to S5 and M1 to M3 defined above, the following categories are prohibited in competition: SUBSTANCES prohibited S6. STIMULANTS all stimulants (including their two optical isomers if applicable) are prohibited, except imidazole topical derivatives and incentives contained in the monitoring program 2011 *.
Stimulants include: has: not specified Stimulants: Adrafinil, amfepramone, amiphenazole, amphetamine, amphetaminil, benfluorex, benzphetamine, benzylpiperazine, bromantan, clobenzorex, cocaine, cropropamide, crotetamide, dimethylamphetamine, etilamphetamine, famprofazone, fencamine, fenetylline, fenfluramine, fenproporex, furfenorex, mefenorex, mephentermine, mesocarb, methamphetamine (d-), p-methylamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, modafinil, norfenfluramine, phendimetrazine, phenmetrazine, phentermine, 4-phenylpiracetam (carphedon), prenylamine, prolintane. A stimulant that is not specifically named in this section is a specified substance.
b: Stimulants specified (examples): Adrenaline *, cathine *, ephedrine *, etamivan, etilefrine, fenbutrazate, fencamfamin, heptaminol, isometheptene, levmetamfetamine, meclofenoxate, methylephedrine *, methylhexaneamine (dimethylpentylamine), methylphenidate, nikethamide, selegiline, octopamine, selegiline, parahydroxyamphetamine, pemoline, pentetrazole, phenpromethamine, propylhexedrine, pseudoephedrine *, selegiline, sibutramine, strychnine, tuaminoheptane. and other substances with a similar chemical structure or (a) effect (s) biological (s) similar (s).
Substances contained in the Monitoring Programme 2011 (bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradrol, synephrine) are not considered as prohibited substances.
* Adrenaline associated with local anaesthetic agents, or in preparation for topical use (e.g. nasal, ophthalmologic) is not prohibited.
Cathine is prohibited when its concentration in urine is greater than 5 micrograms per milliliter.
Ephedrine and methylephedrine is prohibited when their concentration in urine is greater than 10 micrograms per milliliter.
Pseudoephedrine is prohibited when its concentration in urine exceeds 150 micrograms per milliliter.
S7. Narcotics the following is prohibited: Buprenorphine, dextromoramide, diamorphine (heroin), fentanyl and its derivatives, hydromorphone, methadone, morphine, oxycodone, oxymorphone, pentazocine, pethidine.
S8. CANNABINOIDS 9-tetrahydrocannabinol (THC) natural (e.g. cannabis, hashish, marijuana) or synthetic and the cannabimimetics (e.g. the 'Spice' [containing the JWH018, the JWH073], HU-210) are prohibited.
S9. GLUCOCORTICOSTEROIDS all glucocorticosteroids are prohibited when administered by oral, intravenous, intramuscular or rectal.
BANNED IN SOME SPORTS P1. ALCOHOL alcohol (ethanol) is prohibited in-competition only, in the following sports. Detection will be performed by breathalyzer or blood test. The doping violation threshold (haematological values) is 0.10 g/L.
Aeronautic (FAI).
Automobile (FIA).
Karate (WKF).
Motorcycling (FIM).
Speedboat (UIM).
(Nine - and ten-) bowling (FIQ).
TIR à l'Arc (FITA).
P2. -Beta-BLOCKERS unless otherwise specified, beta-blockers are prohibited in-competition only, in the following sports: aeronautic (FAI).
Automobile (FIA).
Billiards and snooker (WCBS).
Bobsleigh and skeleton (FIBT).
Boules (CMSB).
Bridge (FMB).
Curling (WCF).
Darts (WDF).
Golf (IGF).
Wrestling (FILA).
Motorcycling (FIM).
Speedboat (UIM).
Modern pentathlon (UIPM) for disciplines involving shooting.
Skittles (nine-and ten)-(FIQ).
Skiing/snowboarding (FIS) in ski jumping, jumping freestyle/halfpipe and snowboard halfpipe/big air.
Shooting (ISSF, IPC) (also prohibited out of competition).
TIR à l'Arc (FITA) (also prohibited out of competition).
Sailing (ISAF) for match racing only race.
Beta blockers include without limitation: Acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol, carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol, metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol.

Done at Paris, on 16 December 2010.
Nicolas Sarkozy by the President of the Republic: Prime Minister François Fillon Minister of State, Minister of foreign and European Affairs, Michèle Alliot-Marie (1) this amendment will enter into force on January 1, 2011.